We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

235 hedge funds and large institutions have $263M invested in Editas Medicine in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 65 increasing their positions, 72 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $2.6M | Put options by funds: $1.83M

32% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 37

4% more funds holding

Funds holding: 225 → 235 (+10)

10% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 72

14.47% less ownership

Funds ownership: 83.04% → 68.57% (-14%)

48% less capital invested

Capital invested by funds: $504M → $263M (-$240M)

Holders
235
Holders Change
+10
Holders Change %
+4.44%
% of All Funds
3.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
65
Reduced
72
Closed
37
Calls
$2.6M
Puts
$1.83M
Net Calls
+$777K
Net Calls Change
-$2.08M

Top Buyers

1
UBS AM
UBS AM
Illinois
+$4.61M
2
APM
Avidity Partners Management
Texas
+$4.6M
3
DTC
Deep Track Capital
Connecticut
+$2.67M
4
HF
HRT Financial
New York
+$1.68M
5
TI
Trexquant Investment
Connecticut
+$1.54M

Top Sellers

1
State Street
State Street
Massachusetts
-$23.5M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$7.76M
3
Morgan Stanley
Morgan Stanley
New York
-$4.88M
4
Two Sigma Investments
Two Sigma Investments
New York
-$4.78M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$4.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$2.1M -$1.93M -342,167 -43%
UBS Group
27
UBS Group
Switzerland
$1.6M -$1.43M -253,844 -43%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$1.46M +$580K +102,849 +49%
HF
29
HRT Financial
New York
$1.39M +$1.68M +298,030 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.38M +$63.9K +11,332 +4%
Jane Street
31
Jane Street
New York
$1.35M +$707K +125,262 +76%
SOMRS
32
State of Michigan Retirement System
Michigan
$1.28M – – –
ECM
33
ExodusPoint Capital Management
New York
$1.22M +$1.47M +261,381 New
N
34
Nuveen
North Carolina
$1.2M -$4.33M -767,149 -75%
PP
35
PDT Partners
New York
$1.15M +$1.11M +196,041 +388%
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$1.06M +$609K +108,042 +91%
Citadel Advisors
37
Citadel Advisors
Florida
$1.03M -$2.79M -494,583 -69%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$1M -$3.6M -638,222 -75%
Mirae Asset Global ETFs Holdings
39
Mirae Asset Global ETFs Holdings
Hong Kong
$959K +$1.16M +205,138 New
Wells Fargo
40
Wells Fargo
California
$854K +$305K +54,025 +42%
DMKJ
41
David M. Knott Jr
$827K +$209K +37,000 +26%
HWAM
42
Hennion & Walsh Asset Management
New Jersey
$786K +$950K +168,371 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$718K +$50.2K +8,900 +6%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$644K +$21.8K +3,862 +3%
AllianceBernstein
45
AllianceBernstein
Tennessee
$630K +$295K +52,330 +63%
KCM
46
Kennedy Capital Management
Missouri
$619K -$3.19K -566 -0.4%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$612K -$95.5K -16,934 -11%
CANY
48
Caxton Associates (New York)
New York
$600K +$725K +128,510 New
American Century Companies
49
American Century Companies
Missouri
$590K +$85.1K +15,088 +14%
Jennison Associates
50
Jennison Associates
New York
$583K +$104K +18,368 +17%
1
2
3 4 5

EDIT Hedge Fund Activity: Q2 2024 in Review

235 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2024, worth a combined $263M — down 48% from $504M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new EDIT positions and 37 closed out — a net gain of 12 holders — while 65 added to existing stakes and 72 trimmed.

The largest buyer was UBS AM, adding an estimated $4.61M. The largest seller was State Street, cutting an estimated $23.5M.

  • 235 institutional investors held Editas Medicine (EDIT) as of Q2 2024, up from 225 in Q1 2024.
  • Funds reported $263M of Editas Medicine stock for Q2 2024, down 48% quarter-over-quarter.
  • 49 funds opened new Editas Medicine positions in Q2 2024 and 37 closed out, a net change of +12 holders.
  • The largest Editas Medicine buyer in Q2 2024 was UBS AM, an estimated $4.61M added.
  • The largest Editas Medicine seller in Q2 2024 was State Street, an estimated $23.5M sold.

Based on aggregated 13F filings for Q2 2024.